Intellectual disability: An approach from the health sciences perspective

Salud Publica de Mexico

Volumn 50, Issue SUPPL. 2, 2008, Pages

  Salvador Carulla, Luis ^a,d   Rodríguez Blázquez, Carmen ^b   Martorell, Almudena ^c  

^a International College of Person Centered Medicine   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c Fundaci&oavcute n Carmen Pardo Valcarce   (Spain)

^d NONE   (Spain)

Author keywords

Conceptual framework; Health; Intellectual disability

Indexed keywords

EID: 42549147135     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/s0036-36342008000800006     Document Type: Review

References (45)

1. Schalock RL, Luckasson RA, Shogren KA, Borthwick-Duffy S, Bradley V, Buntinx WH, et al. The renaming of mental retardation: understanding the change to the term intellectual disability. Intellect Dev Disabil 2007;45(2):116-124.
2. Salvador-Carulla L, Bertelli M. Mental retardation or intellectual disability: time for a conceptual change. Psychopathology 2008;41:10-16.
3. Durkin M. The epidemiology of developmental disabilities in low-income countries. Ment Retard Dev Disabil Res Rev 2002;8(3):206-211.
4. Polder JJ, Meerding WJ, Bonneux L, van der Maas PJ. Healthcare costs of intellectual disability in the Netherlands: a cost-of-illness perspective. J Intel Disabil Res 2002;46(Pt 2):168-178.
5. American Association on Mental Retardation (AAMR). Mental retardation: definition, classification and systems of supports. 10th ed. Washington, D.C.: American Association on Mental Retardation (AAMR); 2002.
6. Zigler E. Can we "cure" mild mental retardation among individuals in the lower socioeconomic stratum? Am J Public Health 1995;85(3):302-304.
7. Ouellette-Kuntz H, Garcin N, Lewis ME, Minnes P, Martin C, Holden JJ. Addressing health disparities through promoting equity for individuals with intellectual disability. Can J Public Health 2005;96(Suppl 2):S8-22.
8. Flint J, Yule W. Behavioural phenotypes. In: Rutter M, Taylor E, Hersov L, editors. Child and adolescent psychiatry. Oxford: Blackwell Science; 1994. p. 666-687.
9. American Psychiatric Association (APA). Manual diagnóstico y estadístico de los trastornos mentales. 4th ed. (revised text). DSM-IV TR. Barcelona: Masson; 2002.
10. Walsh PN, Kerr M, van Schrojenstein Lantman-de Valk HM. Health indicators for people with intellectual disabilities: a European perspective. Eur J Public Health 2003;13(Suppl 3):47-50.
11. Rodgers J. Primary health care provision for people with learning difficulties. Health Soc Care Comm 1994;2(1):11-17.
12. Kerr MP. Primary health care for people with an intellectual disability. J Intel Disabil Res 1997;41(5):363-364.
13. Cooke LB. Cancer and learning disability. J Intel Disabil Res 1997;41(Pt 4):312-316.
14. Hollins S, Attard MT, von Fraunhofer N, McGuigan S, Sedgwick P. Mortality in people with learning disability: risks, causes, and death certification findings in London. Dev Med Child Neurol 1998;40(1):50-56.
15. Cumella S, Ransford N, Lyons J, Burnham H. Needs for oral care among people with intellectual disability not in contact with Community Dental Services. J Intel Disabil Res 2000;44(Pt 1):45-52.
16. Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol 2002;44(4):248-255.
17. Airaksinen EM, Matilainen R, Mononen T, Mustonen K, Partanen J, Jokela V, et al. A population-based study on epilepsy in mentally retarded children. Epilepsia 2000;41(9):1214-1220.
18. Bohmer CJ, Klinkenberg-Knol EC, Kuipers EJ, Niezen-de Boer MC, Schreuder H, Schuckink-Kool F, et al. The prevalence of Helicobacter pylori infection among inhabitants and healthy employees of institutes for the intellectually disabled. Am J Gastroenterol 1997;92(6):1000-1004.
19. Bohmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, Deville WL, Nadorp JH, Meuwissen SG. The prevalence of gastroesophageal reflux disease in institutionalized intellectually disabled individuals. Am J Gastroenterol 1999;94(3):804-810.
20. Janicki MP, Dalton AJ, Henderson CM, Davidson PW. Mortality and morbidity among older adults with intellectual disability: health services considerations. Disabil Rehabil 1999;21(5-6):284-294.
21. Hilton JM, Fitzgerald DA, Cooper DM. Respiratory morbidity of hospitalized children with trisomy 21. J Paediatr Child Health 1999;35(4):383-386.
22. Schrojenstein Lantman-de Valk HM, van den AM, Maaskant MA, Haveman MJ, Urlings HF, Kessels AG, et al. Prevalence and incidence of health problems in people with intellectual disability. J Intel Disabil Res 1997;41(Pt 1):42-51.
23. Band R. The NHS: health for all? Londres: Mencap National Centre; 1998.
24. Cooper SA, Smiley E, Finlayson J, Jackson A, Allan L, Williamson A, et al. The prevalence, incidence, and factors predictive of mental ill-health in adults with profound intellectual disabilities. Prospective study. J Appl Res Int Dis 2007;20:493-501.
25. Salvador-Carulla L, Rodríguez-Blazquez C, Rodriguez DM, Perez-Marin J, Velazquez R. Hidden psychiatric morbidity in a vocational programme for people with intellectual disability. J Intel Disabil Res 2000;44(Pt 2):147-154.
26. Collacott RA, Cooper SA, McGrother C. Differential rates of psychiatric disorders in adults with Down's syndrome compared with other mentally handicapped adults. Br J Psychiatry 1992;161:671-674.
27. Salvador-Carulla L, Novell R. Guía práctica de la evaluación psiquiátrica en el retraso mental. Barcelona: Aula Médica; 2002.
28. Hemmings CP, Gravestock S, Pickard M, Bouras N. Psychiatric symptoms and problem behaviours in people with intellectual disabilities. J Intel Disabil Res 2006;50(Pt 4):269-276.
29. Royal College of Psychiatrists. Diagnostic criteria for psychiatric disorders for use with adults with learning disabilities/mental retardation, DC-LD. London: Royal College of Psychiatrists; 2001.
30. Fletcher R, Loschen E, Stavrakaki C, First M. Diagnostic Manual-Intellectual Disability (DM-ID): a textbook of diagnosis of mental disorders in persons with intellectual disability. Kingston, NY: NADD Press; 2007.
31. Sovner R. Limiting factors in the use of DSM-III criteria with mentally ill/mentally retarded persons. Psychopharmacol Bull 1986;22(4):1055-1059.
32. Szymanski L, King BH. Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry 1999;38(12 Suppl):5S-31S.
33. Reiss S, Levitan GW, Szyszko J. Emotional disturbance and mental retardation: diagnostic overshadowing. Am J Ment Defic 1982;86(6):567-574.
34. Emerson E, Bromley J. The form and function of challenging behaviours. J Intel Disabil Res 1995;39(Pt 5):388-398.
35. Novell R, Salvador-Carulla L. Problemas de conducta en el retraso mental. Siglo Cero Rev Esp Discap Intel 2003;34:78-86.
36. Emerson E, Barrett S, Bell C, Cummings R, McCool C, Toogood A, et al. Developing services for people with severe learning disabilities and severe challenging behaviours. Canterbury: University of Kent at Canterbury, Institute of Social and Applied Psychology; 1987.
37. Bruininks RH, Hill BH, Weatherman RF, Woodcock RW. Inventory for client and agency planning, ICAP. Allen, TX.: DLM Teaching Resources; 1986.
38. Rojahn J, Matson JL, Naglieri JA, Mayville E. Relationships between psychiatric conditions and behavior problems among adults with mental retardation. Am J Ment Retard 2004;109(1):21-33.
39. Grey IM, Hastings RP. Evidence-based practices in intellectual disability and behaviour disorders. Curr Opin Psychiatry 2005;18(5):469-475.
40. Ferrell RB, Wolinsky EJ, Kauffman CI, Flashman LA, McAllister TW. Neuropsychiatric syndromes in adults with intellectual disability: issues in assessment and treatment. Curr Psychiatry Rep 2004; 6(5):380-390.
41. Bokszanska A, Martin G, Vanstraelen M, Holt G, Bouras N, Taylor D. Risperidone and olanzapine in adults with intellectual disability: a clinical naturalistic study. Int Clin Psychopharmacol 2003;18(5):285-291.
42. Deb S, Clarke D, Unwin G. Using medication to manage behaviour problems among adults with a learning disability. Quick reference guide. Birmingham: University of Birmingham, Royal College of Psychiatrists and Mencap; 2006.
43. Kandel I, Morad M, Merrick J. Health Needs Assessment Report: people with learning disabilities in Scotland. J Pol Prac Intel Disabil 2004;1(2):113-114.
44. U.S. Public Health Service. Closing the gap: a national blueprint for improving the health of individuals with mental retardation. Report of the surgeon general's conference on health disparities and mental retardation. Washington, D.C.: U.S. Public Health Service; 2002.
45. Dosen A, Bouras N, Bradl C, Salvador-Carulla L, Efthimiopoulou G, et al. Functional Rehabilitation: Supporting Persons with Mental Retardation. Working Group 3; Helios II Programme 1993-1996. Brussels: European Commission; 1997.